Stoke Therapeutics, Inc. (STOK) — Net Income

Annual figures by fiscal year, from SEC filings.

2018: -$12.52M2019: -$32.33M2020: -$52.24M2021: -$85.81M2022: -$101.07M2023: -$104.70M2024: -$88.98M2025: -$6.88M-$6.88M
2018Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$6.88M+92.3%
2024-$88.98M+15.0%
2023-$104.70M-3.6%
2022-$101.07M-17.8%
2021-$85.81M-64.2%
2020-$52.24M-61.6%
2019-$32.33M-158.2%
2018-$12.52M